Unknown

Dataset Information

0

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes.


ABSTRACT: Achieving hypertension (HTN) control and mitigating the adverse health effects associated with HTN continues to be a global challenge. Some individuals respond poorly to current HTN therapies, and mechanisms for response variation remain poorly understood. We used a nontargeted metabolomics approach (gas chromatography time-of-flight/mass spectrometry gas chromatography time-of-flight/mass spectrometry) measuring 489 metabolites to characterize metabolite signatures associated with treatment response to anti-HTN drugs, atenolol (ATEN), and hydrochlorothiazide (HCTZ), in white and black participants with uncomplicated HTN enrolled in the Pharmacogenomic Evaluation of Antihypertensive Responses study. Metabolite profiles were significantly different between races, and metabolite responses associated with home diastolic blood pressure (HDBP) response were identified. Metabolite pathway analyses identified gluconeogenesis, plasmalogen synthesis, and tryptophan metabolism increases in white participants treated with HCTZ (P?

SUBMITTER: Rotroff DM 

PROVIDER: S-EPMC4716583 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes.

Rotroff D M DM   Shahin M H MH   Gurley S B SB   Zhu H H   Motsinger-Reif A A   Meisner M M   Beitelshees A L AL   Fiehn O O   Johnson J A JA   Elbadawi-Sidhu M M   Frye R F RF   Gong Y Y   Weng L L   Cooper-DeHoff R M RM   Kaddurah-Daouk R R  

CPT: pharmacometrics & systems pharmacology 20151029 11


Achieving hypertension (HTN) control and mitigating the adverse health effects associated with HTN continues to be a global challenge. Some individuals respond poorly to current HTN therapies, and mechanisms for response variation remain poorly understood. We used a nontargeted metabolomics approach (gas chromatography time-of-flight/mass spectrometry gas chromatography time-of-flight/mass spectrometry) measuring 489 metabolites to characterize metabolite signatures associated with treatment res  ...[more]

Similar Datasets

| S-EPMC2765524 | biostudies-literature
| S-EPMC4227953 | biostudies-literature
| S-EPMC3288583 | biostudies-literature
| S-EPMC3594230 | biostudies-literature
| S-EPMC3958600 | biostudies-literature
| S-EPMC6776548 | biostudies-literature
2014-07-22 | E-GEOD-50208 | biostudies-arrayexpress
| S-EPMC3848568 | biostudies-literature
2014-07-22 | GSE50208 | GEO
| S-ECPF-GEOD-58700 | biostudies-other